Capital Rx recently closed a $106 million Series C funding round, bringing its overall funding to $175 million. The upstart pharmacy benefit manager will use the funds to enhance its digital pharmacy platform as well as grow its user base.
Industry experts from Syneos and Medable will share their perspectives on how to address these drug development challenges within cardiometabolic clinical studies and provide input on the impact of new regulatory guidance such as the DEPICT Act.
This engaging panel will discuss leveraging technology and home health solutions to augment existing points of care between patients and their clinical care team to improve the patient experience, drive more scientific rigor to data generation and achieve timely endpoint capture.
Don't miss out on this valuable opportunity to meet and discuss the latest trends and opportunities. Don't miss your chance to save with the Super Early Bird Rate.
Biopharmaceutical companies and public health officials have learned a great deal about pandemic response in the last two years. A panel discussion during the annual meeting of the Biotechnology Innovation Organization explored some of the lessons from Covid-19 and how they can prepare us for the next pandemic.
Medical algorithms will continue to preserve the racial bias that has been historically baked into the U.S. healthcare system unless the medical field stops operationalizing race in its machine learning models, according to panelists at a recent panel hosted by the Philadelphia Alliance for Capital and Technologies. They argued algorithms should use social determinants of health as a predictor of health outcomes instead of race.
By Dr. Samuel Browd Tuesday, June 14, 2022 4:30 PM
While AI has significant transformative potential and fully autonomous surgery is something our industry can aspire to, there is a lot we can accomplish in the conversation around AI in the meantime. This means technologists need to collaborate with healthcare providers to align in our approach to embracing AI.
At the MedCity INVEST PharmaTech virtual conference July 26, strategies and alignment between digital and pharma companies will be a major theme of the conference. Register now to join the conversation.
ImCheck Therapeutics aims to broaden the reach of cancer immunotherapy with antibody drugs that activate a rare but powerful type of immune cell called gamma delta T cells. The biotech has unveiled €96 million to advance its pipeline, including a lead candidate in development for both liquid and solid tumors.
RPM as we know it today – with all its advantages – falls short. The reason? Monitoring and alerting alone cannot provide one of the most critical parts of healthcare: care itself.
-Recovered.png?width=1200&height=400&upscale=true&name=DIgital%20Health%20Header(1)-Recovered.png)
No comments